Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Technology Scientific & Technical Instruments
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal

PR Newswire September 18, 2018

Bio-Techne Fills a Need for Simple Tools to Study Glycobiology

PR Newswire September 6, 2018

Bio-Techne To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

PR Newswire September 5, 2018

Bio-Techne To Present At The Baird 2018 Global Healthcare Conference

PR Newswire August 28, 2018

Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development

PR Newswire August 8, 2018

Bio-Techne Declares Dividend

PR Newswire August 7, 2018

Bio-Techne Releases Fourth Quarter Fiscal 2018 Results

PR Newswire August 7, 2018

Bio-Techne Announces 2018 Investor Day And Webcast

PR Newswire August 2, 2018

Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.

PR Newswire August 1, 2018

Bio-Techne Introduces New Member of the Simple Western™ Family, with IR/NIR Detection Capabilities

PR Newswire July 24, 2018

Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results

PR Newswire July 12, 2018

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

PR Newswire July 10, 2018

Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs

PR Newswire June 26, 2018

Bio-Techne To Acquire Exosome Diagnostics, Inc.

PR Newswire June 25, 2018

Bio-Techne To Acquire Quad Technologies

PR Newswire June 7, 2018

Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference

PR Newswire June 4, 2018

Bio-Techne To Present At The Jefferies 2018 Healthcare Conference

PR Newswire May 24, 2018

Bio-Techne To Present At The UBS Global Healthcare Conference

PR Newswire May 10, 2018

Bio-Techne Declares Dividend

PR Newswire May 2, 2018

Bio-Techne Releases Third Quarter Fiscal 2018 Results

PR Newswire May 2, 2018